While we have performed many projects for senior’s looking to stay in their home longer, the majority of our projects are done for individuals facing a disease or disability.
Lyt Phage is a start up biotech company developing novel therapeutics for the treatment of anitbiotic resistant infections.
1986-1988 Coordinate the Medicinal Chemistry research programs for three disease areas; Antiinflammatory, Antimicrobial and Cancer disease and also the Medicinal Chemistry Synthesis Group.
During this time I continued my personal research in the Cancer Chemotherapy area that was related to phosphotidylinositol transmembrane signaling and applications of computer modeling to chemistry.
The major efforts of this group were patent preparation, strategy, the technical and scientific aspects of patent prosecution and patent portfolio management.
1990-1991 Developed the Phase II clinical trial strategy and design for anthrapyrazole cancer therapeutic agents.
I facilitated and coordinated the interdepartmental planning of technology related to agricultural, pharmaceutical and diagnostic research.I helped business development evaluate and rank potential in-licensing candidates.I was a member of the due diligence team providing background for prospective partners.The efforts were concentrated on glutamate excitatory amino acid receptors.1992-1993 I directed a group within R&D that was responsible for patent liaison, grant, contract and publication administration.